EcoDrugPlus

Mapk Activated Protein Kinase 2

Ensembl ID : ENSMMDG00005024061
Gene Symbol: MAPKAPK2
3 Cross references
187 Possible Orthologues:

Mapk Activated Protein Kinase 5

Ensembl ID : ENSMMDG00005017645
Gene Symbol: MAPKAPK5
3 Cross references
179 Possible Orthologues:

Mdm2 Proto-Oncogene

Ensembl ID : ENSMMDG00005007595
Gene Symbol: MDM2
3 Cross references
275 Possible Orthologues:

Met Proto-Oncogene, Receptor Tyrosine Kinase

Ensembl ID : ENSMMDG00005007743
Gene Symbol: MET
1 Cross references
205 Possible Orthologues:

Mtor Associated Protein, Lst8 Homolog

Ensembl ID : ENSMMDG00005002561
Gene Symbol: MLST8
3 Cross references
198 Possible Orthologues:

N-Acetylated Alpha-Linked Acidic Dipeptidase 2

Ensembl ID : ENSMMDG00005021508
Gene Symbol: NAALAD2
1 Cross references
340 Possible Orthologues:

Npc1 Like Intracellular Cholesterol Transporter 1

Ensembl ID : ENSMMDG00005000864
Gene Symbol: NPC1L1
1 Cross references
189 Possible Orthologues:

P2x Purinoceptor 3-Like

Ensembl ID : ENSMMDG00005009139
Gene Symbol: LOC115366548
3 Cross references
192 Possible Orthologues:

Ptk6 Protein Tyrosine Kinase 6b

Ensembl ID : ENSMMDG00005011471
Gene Symbol: PTK6B
1 Cross references
159 Possible Orthologues:

Pim-3 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSMMDG00005017726
Gene Symbol: PIM3
3 Cross references
172 Possible Orthologues:

Rac-Beta Serine/threonine-Protein Kinase-Like

Ensembl ID : ENSMMDG00005002889
Gene Symbol: LOC115371125
3 Cross references
163 Possible Orthologues:

Raf-1 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSMMDG00005018107
Gene Symbol: RAF1
3 Cross references
207 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).